Cytotoxic Pentaketide-Sesquiterpenes from the Marine-Derived Fungus Talaromyces variabilis M22734
Marine Drugs · 2024
DOI: 10.3390/md22060274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Lingzhi Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Xiamen Key Laboratory of Marine Medicinal Natural Products Resources, Xiamen Medical College, Xiamen 361023, China. Hauptthemen laut MEDLINE: Talaromyces, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific Research Foundation of the Third Institute of Oceanography, MNR, The Natural Science Foundation of Xiamen, The Open Project of Key Laboratory of Marine Biogenetic Resources, Third Institute of Oceanography, Ministry of Natural Resources.
Abstract (Originalsprache)
Talaromyces, a filamentous fungus widely distributed across terrestrial and marine environments, can produce a diverse array of natural products, including alkaloids, polyketones, and polyketide-terpenoids. Among these, chrodrimanins represented a typical class of natural products. In this study, we isolated three previously undescribed pentaketide-sesquiterpenes, 8,9-epi-chrodrimanins (1–3), along with eight known compounds (4–11). The structures of compounds 1–3 were elucidated using nuclear magnetic resonance (NMR) and mass spectrometry (MS), while their absolute configurations were determined through X-ray crystallography and electronic circular dichroism (ECD) computations. The biosynthetic pathways of compounds 1–3 initiate with 6-hydroxymellein and involve multiple stages of isoprenylation, cyclization, oxidation, and acetylation. We selected four strains of gastrointestinal cancer cells for activity evaluation. We found that compound 3 selectively inhibited MKN-45, whereas compounds 1 and 2 exhibited no significant inhibitory activity against the four cell lines. These findings suggested that 8,9-epi-chrodrimanins could serve as scaffold compounds for further structural modifications, potentially leading to the development of targeted therapies for gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiamen Key Laboratory of Marine Medicinal Natural Products Resources, Xiamen Medical College, Xiamen 361023, China.
- Key Laboratory of Marine Biogenetic Resources, Third Institute of Oceanography, Ministry of Natural Resources, Xiamen 361005, China.
- School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
ORCID-Profile: Jinmei Xia, Weiyi Wang, Xuan Hong
Förderung
- The Scientific Research Foundation of the Third Institute of Oceanography, MNR
- The Natural Science Foundation of Xiamen
- The Open Project of Key Laboratory of Marine Biogenetic Resources, Third Institute of Oceanography, Ministry of Natural Resources
- The Research Project of Xiamen Medical College
- Xiamen Southern Oceanographic Center Project
- The Natural Science Foundation of Fujian Province
- Scientific Research Foundation of the Third Institute of Oceanography, MNR
- Natural Science Foundation of Xiamen
Zitieren
APA
Tang, L., Xia, J., Chen, Z., Wu, X., Li, G., Lai, Q., Shao, Z., Wang, W., & Hong, X. (2024). Cytotoxic Pentaketide-Sesquiterpenes from the Marine-Derived Fungus Talaromyces variabilis M22734. Marine Drugs. https://doi.org/10.3390/md22060274
Vancouver
Tang L, Xia J, Chen Z, Wu X, Li G, Lai Q, et al. Cytotoxic Pentaketide-Sesquiterpenes from the Marine-Derived Fungus Talaromyces variabilis M22734. Marine Drugs. 2024. doi:10.3390/md22060274
BibTeX
@article{Tang2024,
author = {Tang, Lingzhi and Xia, Jinmei and Chen, Zhongwei and Wu, Xiaohui and Li, Guangyu and Lai, Qiliang and Shao, Zongze and Wang, Weiyi and Hong, Xuan},
title = {Cytotoxic Pentaketide-Sesquiterpenes from the Marine-Derived Fungus Talaromyces variabilis M22734},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22060274}
}
EUVIMED